Alimera Historical Income Statement

ALIM Stock  USD 3.52  0.33  8.57%   
Historical analysis of Alimera Sciences income statement accounts such as Interest Expense of 10.7 M, Selling General Administrative of 11.1 M or Selling And Marketing Expenses of 17.2 M can show how well Alimera Sciences performed in making a profits. Evaluating Alimera Sciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Alimera Sciences's future profits or losses.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Alimera Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Alimera Sciences is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.

About Alimera Income Statement Analysis

Alimera Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Alimera Sciences shareholders. The income statement also shows Alimera investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Alimera Sciences Income Statement Chart

Alimera Sciences Income Statement is one of the three primary financial statements used for reporting Alimera's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Alimera Sciences revenue and expense. Alimera Sciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Alimera Sciences' Depreciation And Amortization is very stable compared to the past year. As of the 16th of April 2024, Interest Expense is likely to grow to about 10.7 M, while Selling And Marketing Expenses is likely to drop about 17.2 M.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Alimera Sciences. It is also known as Alimera Sciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Alimera Sciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Alimera Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.At this time, Alimera Sciences' Depreciation And Amortization is very stable compared to the past year. As of the 16th of April 2024, Interest Expense is likely to grow to about 10.7 M, while Selling And Marketing Expenses is likely to drop about 17.2 M.
 2021 2022 2023 2024 (projected)
Interest Expense5.4M5.9M10.2M10.7M
Depreciation And Amortization2.6M2.7M8.7M9.2M

Alimera Sciences income statement Correlations

0.950.580.480.640.530.530.530.660.560.16-0.650.17-0.440.880.660.230.960.14-0.11-0.64-0.880.73
0.950.710.660.780.550.550.680.660.730.23-0.540.26-0.590.950.810.350.910.21-0.07-0.77-0.780.6
0.580.710.940.970.120.120.840.220.96-0.08-0.22-0.05-0.790.680.790.080.50.150.03-0.66-0.270.45
0.480.660.940.960.070.070.840.150.99-0.06-0.09-0.03-0.790.640.780.110.390.210.06-0.68-0.170.25
0.640.780.970.960.250.250.90.340.980.06-0.270.09-0.760.770.870.210.580.190.02-0.71-0.360.46
0.530.550.120.070.251.00.110.990.130.84-0.560.85-0.010.720.670.840.65-0.10.03-0.58-0.440.34
0.530.550.120.070.251.00.110.990.120.84-0.570.840.00.720.670.840.65-0.10.02-0.57-0.440.35
0.530.680.840.840.90.110.110.20.890.01-0.110.03-0.610.630.730.120.470.360.08-0.5-0.380.44
0.660.660.220.150.340.990.990.20.210.78-0.630.78-0.080.810.720.790.76-0.060.0-0.63-0.550.44
0.560.730.960.990.980.130.120.890.21-0.02-0.130.01-0.790.70.810.140.470.240.06-0.69-0.260.31
0.160.23-0.08-0.060.060.840.840.010.78-0.02-0.051.00.190.420.50.960.230.240.12-0.33-0.040.01
-0.65-0.54-0.22-0.09-0.27-0.56-0.57-0.11-0.63-0.13-0.05-0.060.2-0.6-0.39-0.09-0.80.580.150.430.71-0.62
0.170.26-0.05-0.030.090.850.840.030.780.011.0-0.060.140.450.530.980.250.240.11-0.35-0.050.01
-0.44-0.59-0.79-0.79-0.76-0.010.0-0.61-0.08-0.790.190.20.14-0.55-0.57-0.06-0.41-0.060.140.50.23-0.16
0.880.950.680.640.770.720.720.630.810.70.42-0.60.45-0.550.910.530.90.080.01-0.82-0.670.52
0.660.810.790.780.870.670.670.730.720.810.5-0.390.53-0.570.910.620.670.120.07-0.83-0.370.42
0.230.350.080.110.210.840.840.120.790.140.96-0.090.98-0.060.530.620.310.250.12-0.43-0.080.03
0.960.910.50.390.580.650.650.470.760.470.23-0.80.25-0.410.90.670.31-0.02-0.12-0.6-0.90.73
0.140.210.150.210.19-0.1-0.10.36-0.060.240.240.580.24-0.060.080.120.25-0.020.00.07-0.030.01
-0.11-0.070.030.060.020.030.020.080.00.060.120.150.110.140.010.070.12-0.120.0-0.040.19-0.19
-0.64-0.77-0.66-0.68-0.71-0.58-0.57-0.5-0.63-0.69-0.330.43-0.350.5-0.82-0.83-0.43-0.60.07-0.040.38-0.27
-0.88-0.78-0.27-0.17-0.36-0.44-0.44-0.38-0.55-0.26-0.040.71-0.050.23-0.67-0.37-0.08-0.9-0.030.190.38-0.73
0.730.60.450.250.460.340.350.440.440.310.01-0.620.01-0.160.520.420.030.730.01-0.19-0.27-0.73
Click cells to compare fundamentals

Alimera Sciences Account Relationship Matchups

Alimera Sciences income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization2.6M2.7M2.6M2.7M8.7M9.2M
Interest Expense4.9M5.4M5.4M5.9M10.2M10.7M
Selling General Administrative14.0M11.7M12.8M12.9M18.5M11.1M
Selling And Marketing Expenses25.0M20.4M23.1M26.0M27.9M17.2M
Other Operating Expenses59.2M51.3M59.2M65.8M82.2M48.2M
Operating Income(5.3M)(501K)(201K)(11.6M)(1.5M)(1.5M)
Ebit(5.3M)(501K)(201K)(11.6M)(1.5M)(1.5M)
Research Development11.0M9.7M13.8M16.2M16.6M10.7M
Ebitda(2.6M)2.2M2.4M(8.9M)7.3M7.6M
Total Operating Expenses52.6M44.4M52.2M57.8M62.6M44.3M
Income Before Tax(10.2M)(5.4M)(3.9M)(18.1M)(20.0M)(21.0M)
Total Other Income Expense Net(5.0M)(4.9M)(3.7M)(6.4M)(18.6M)(17.6M)
Net Income(10.4M)(5.3M)(4.4M)(18.1M)(20.1M)(21.1M)
Income Tax Expense216K(68K)438K28K85K80.8K
Total Revenue53.9M50.8M59.0M54.1M80.8M84.8M
Gross Profit47.3M43.9M52.0M46.2M61.2M32.6M
Net Income From Continuing Ops(10.4M)(5.3M)(4.4M)(18.1M)(20.1M)(21.1M)
Cost Of Revenue6.6M6.9M7.0M8.0M19.6M20.6M
Non Operating Income Net Other193K(1.8M)(84K)474K545.1K337.2K
Net Income Applicable To Common Shares21.9M(10.4M)(5.3M)(4.4M)(5.0M)(5.3M)
Tax Provision216K(68K)438K28K77K112.2K
Net Interest Income(4.9M)(5.4M)(5.4M)(5.9M)(7.1M)(7.4M)
Reconciled Depreciation2.6M2.7M2.6M2.7M6.4M3.5M

Pair Trading with Alimera Sciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alimera Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alimera Sciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Alimera Stock

  0.52DNA Ginkgo Bioworks Holdings Financial Report 8th of May 2024 PairCorr
  0.41MRK Merck Company Report 25th of April 2024 PairCorr
The ability to find closely correlated positions to Alimera Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alimera Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alimera Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alimera Sciences to buy it.
The correlation of Alimera Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alimera Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alimera Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alimera Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Alimera Sciences is a strong investment it is important to analyze Alimera Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alimera Sciences' future performance. For an informed investment choice regarding Alimera Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Alimera Stock analysis

When running Alimera Sciences' price analysis, check to measure Alimera Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alimera Sciences is operating at the current time. Most of Alimera Sciences' value examination focuses on studying past and present price action to predict the probability of Alimera Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alimera Sciences' price. Additionally, you may evaluate how the addition of Alimera Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Is Alimera Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.84)
Revenue Per Share
3.159
Quarterly Revenue Growth
0.875
Return On Assets
(0.01)
Return On Equity
(1.59)
The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.